David L H Bennett Selected Research

David L H Bennett Research Topics

Disease

22	Pain (Aches) 11/2021 - 04/2010
17	Neuralgia (Stump Neuralgia) 10/2023 - 04/2011
7	Hypersensitivity (Allergy) 10/2023 - 04/2011
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 04/2013
4	Peripheral Nerve Injuries 10/2023 - 04/2010
4	Erythromelalgia (Erythermalgia) 12/2014 - 05/2012
2	Wounds and Injuries (Trauma) 10/2023 - 01/2022
2	Polyneuropathies (Polyneuropathy) 01/2022 - 01/2016
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022 - 03/2017
2	Somatoform Disorders (Somatoform Disorder) 01/2020 - 12/2014
2	Inflammation (Inflammations) 01/2020 - 01/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 01/2016
2	Small Fiber Neuropathy 05/2017 - 06/2014
2	Paroxysmal Extreme Pain Disorder 12/2014 - 06/2014
1	Nervous System Trauma 10/2023
1	Brain Diseases (Brain Disorder) 01/2020
1	Myoclonus (Nocturnal Myoclonus) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Tremor (Tremors) 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Leprosy (Hansen's Disease) 11/2019
1	Anxiety Disorders (Anxiety Disorder) 08/2019
1	Chronic Pain 08/2019
1	Postoperative Pain 08/2019
1	Contusions 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2018
1	Neurodevelopmental Disorders 10/2017
1	Diabetes Mellitus 05/2017
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 05/2017
1	Alzheimer Disease (Alzheimer's Disease) 04/2017
1	Demyelinating Diseases (Demyelinating Disease) 04/2017
1	Dementia (Dementias) 01/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2015
1	Cognitive Dysfunction 11/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2014
1	Painful Neuropathy 06/2014
1	Congenital Pain Insensitivity 06/2014

Drug/Important Bio-Agent (IBA)

8	Analgesics (Analgesic Drugs)IBA 08/2019 - 07/2011
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2011
5	Neuregulin-1 (Neuregulin 1)IBA 01/2019 - 03/2011
4	CytokinesIBA 01/2020 - 07/2011
3	Ion Channels (Ion Channel)IBA 01/2023 - 12/2014
3	NAD (NADH)IBA 01/2022 - 05/2016
3	Amyloid (Amyloid Fibrils)IBA 10/2019 - 01/2016
3	Voltage-Gated Sodium ChannelsIBA 06/2014 - 05/2012
2	Nerve Growth Factor (NGF)IBA 01/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
2	EnzymesIBA 11/2021 - 01/2018
2	MMEIBA 10/2019 - 01/2016
2	Neprilysin (Neutral Endopeptidase)IBA 10/2019 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 04/2011
2	AntibodiesIBA 10/2017 - 11/2011
2	NucleosidesIBA 01/2017 - 04/2013
2	Reverse Transcriptase InhibitorsIBA 01/2017 - 04/2013
2	Sodium Channels (Sodium Channel)IBA 06/2014 - 06/2013
2	ChemokinesIBA 11/2013 - 07/2011
1	Potassium Channels (Potassium Channel)IBA 11/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2020
1	Glycine Receptors (Glycine Receptor)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	AntigensIBA 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Calcitonin Gene-Related PeptideIBA 01/2020
1	Aquaporins (Water Channels)IBA 01/2020
1	PlasticsIBA 01/2020
1	Calcium Channels (Calcium Channel)IBA 01/2020
1	amphiphysinIBA 01/2020
1	Pain-FreeIBA 11/2019
1	Substance PIBA 10/2019
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 08/2019
1	anandamide (arachidonylethanolamide)IBA 08/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	1-deoxysphingolipidIBA 01/2019
1	Serine C-PalmitoyltransferaseIBA 01/2018
1	CalciumIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Complement System Proteins (Complement)IBA 04/2017
1	Immunoglobulin M (IgM)IBA 04/2017
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2017
1	Indinavir (Crixivan)FDA Link 01/2017
1	HIV Protease InhibitorsIBA 01/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Superoxide Dismutase-1IBA 04/2015
1	PrionsIBA 11/2014
1	Triglycerides (Triacylglycerol)IBA 09/2014
1	Transient Receptor Potential ChannelsIBA 06/2014
1	incobotulinumtoxinA FDA Link 04/2014

Therapy/Procedure

7	Therapeutics 10/2023 - 07/2011
2	Nerve Crush 10/2023 - 07/2013
2	Ligation 10/2023 - 10/2013
2	Drug Therapy (Chemotherapy) 01/2022 - 05/2017
2	Intravenous Injections 01/2017 - 04/2013
1	Length of Stay 01/2022
1	Immunotherapy 01/2020
1	Analgesia 08/2019